{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:57:00Z","timestamp":1760954220201,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited multiple cancer syndrome of neuroendocrine tissues. Tumors are caused by an inherited germinal heterozygote inactivating mutation of the MEN1 tumor suppressor gene, followed by a somatic loss of heterozygosity (LOH) of the MEN1 gene in target neuroendocrine cells, mainly at parathyroids, pancreas islets, and anterior pituitary. Over 1500 different germline and somatic mutations of the MEN1 gene have been identified, but the syndrome is completely missing a direct genotype-phenotype correlation, thus supporting the hypothesis that exogenous and endogenous factors, other than MEN1 specific mutation, are involved in MEN1 tumorigenesis and definition of individual clinical phenotype. Epigenetic factors, such as microRNAs (miRNAs), are strongly suspected to have a role in MEN1 tumor initiation and development. Recently, a direct autoregulatory network between miR-24, MEN1 mRNA, and menin was demonstrated in parathyroids and endocrine pancreas, showing a miR-24-induced silencing of menin expression that could have a key role in initiation of tumors in MEN1-target neuroendocrine cells. Here, we review the current knowledge on the post-transcriptional regulation of MEN1 and menin expression by miR-24, and its possible direct role in MEN1 syndrome, describing the possibility and the potential approaches to target and silence this miRNA, to permit the correct expression of the wild type menin, and thereby prevent the development of cancers in the target tissues.<\/jats:p>","DOI":"10.3390\/ijms22147352","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T10:42:17Z","timestamp":1625740937000},"page":"7352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy"],"prefix":"10.3390","volume":"22","author":[{"given":"Francesca","family":"Marini","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy"},{"name":"F.I.R.M.O., Italian Foundation for the Research on Bone Diseases, Via Reginaldo Giuliani 195\/A, 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"F.I.R.M.O., Italian Foundation for the Research on Bone Diseases, Via Reginaldo Giuliani 195\/A, 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple Endocrine Neoplasia Type 1: Latest Insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ando.2021.03.005","article-title":"New therapies for patients with multiple endocrine neoplasia type 1","volume":"82","author":"Geslot","year":"2021","journal-title":"Ann. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Cadiot","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"ref_6","first-page":"4371","article-title":"Somatic mutations in MEN type 1 tumors, consistent with the Knudson \u201ctwo-hit\u201d hypothesis","volume":"86","author":"Pannett","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","first-page":"2685","article-title":"Multiple endocrine neoplasia type 1 (MEN1): LOH studies in an affected family and in sporadic cases","volume":"18","author":"Valdes","year":"1998","journal-title":"Anticancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-17-0281","article-title":"Twenty years of menin: Emerging opportunities for restoration of transcriptional regulation in MEN1","volume":"24","author":"Dreijerink","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"T147","DOI":"10.1530\/ERC-17-0298","article-title":"Epigenetic regulation by the menin pathway","volume":"24","author":"Feng","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Marini, F., Giusti, F., Tonelli, F., and Brandi, M.L. (2021). Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084041"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_14","first-page":"83","article-title":"MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions","volume":"3","author":"Shukla","year":"2011","journal-title":"Mol. Cell Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-62703-748-8_2","article-title":"The role of microRNAs in biological processes","volume":"1107","author":"Meuwissen","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tcb.2014.11.004","article-title":"The biological functions of miRNAs: Lessons from in vivo studies","volume":"25","author":"Vidigal","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lin, Y.-C., Tso-Hsiao Chen, T.-H., Huang, Y.-M., Wei, P.-L., and Lin, J.-C. (2021). Involvement of microRNA in Solid Cancer: Role and Regulatory Mechanisms. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040343"},{"key":"ref_19","first-page":"2735","article-title":"MicroRNAs and cancer: Key paradigms in molecular therapy","volume":"15","author":"Tan","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_20","first-page":"255","article-title":"Regulation of microRNAs in cancer metastasis","volume":"1845","author":"Bouyssou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcancer.2017.02.004","article-title":"Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention","volume":"44","author":"Jafri","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mehy.2016.12.007","article-title":"MEN1 and microRNAs: The link between sporadic pituitary, parathyroid and adrenocortical tumors?","volume":"99","author":"Nagy","year":"2017","journal-title":"Med. Hypotheses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-017-2158-3","article-title":"MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism","volume":"471","author":"Grolmusz","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1002\/ctm2.351","article-title":"MicroRNAs regulatory networks governing the epigenetic landscape of MEN1 gastro-entero-pancreatic neuroendocrine tumor: A case report","volume":"11","author":"Luzi","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Donati, S., Ciuffi, S., Marini, F., Palmini, G., Miglietta, F., Aurilia, C., and Brandi, M.L. (2020). Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207592"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.molcel.2009.08.020","article-title":"miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to \u201cseedless\u201d 3\u2019UTR microRNA recognition elements","volume":"35","author":"Lal","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Luzi, E., Marini, F., Giusti, F., Galli, G., Cavalli, L., and Brandi, M.L. (2012). The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the \u201cKnudson\u2019s second hit\u201d. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039767"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1749-6632.1994.tb17289.x","article-title":"The human carcinoid cell line, BON. A model system for the study of carcinoid tumors","volume":"733","author":"Evers","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1039\/C6MB00118A","article-title":"An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells","volume":"12","author":"Luzi","year":"2016","journal-title":"Mol. Biosyst."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4103\/0366-6999.232793","article-title":"Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats","volume":"131","author":"Gao","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jss.2017.05.020","article-title":"Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2(\u2212\/\u2212) mice","volume":"217","author":"Hall","year":"2017","journal-title":"J. Surg. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/jcp.27017","article-title":"MiR-24-3p regulates cell proliferation and milk protein synthesis of mammary epithelial cells through menin in dairy cows","volume":"234","author":"Qiaoqiao","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: The latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr. Relat. Cancer."},{"key":"ref_34","first-page":"1743","article-title":"Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas","volume":"9","author":"Luzi","year":"2017","journal-title":"Am. J. Transl Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/GIM.0b013e3181be5c97","article-title":"Multiple endocrine neoplasia type 1 (MEN1): Not only inherited endocrine tumors","volume":"11","author":"Falchetti","year":"2009","journal-title":"Genet. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1152\/ajpendo.00542.2013","article-title":"miR-24 regulates menin in the endocrine pancreas","volume":"307","author":"Vijayaraghavan","year":"2014","journal-title":"Am. J. Physiol Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajpath.2016.10.021","article-title":"miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation","volume":"187","author":"Ehrlich","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_38","first-page":"2342","article-title":"miR-24 may be a negative regulator of menin in lung cancer","volume":"39","author":"Pan","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.arbres.2009.11.007","article-title":"Bronchial carcinoid and type 1 multiple endocrine neoplasia syndrome. A case report","volume":"46","author":"Montero","year":"2010","journal-title":"Arch. Bronconeumol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s11033-012-2326-0","article-title":"The tumor suppressor protein menin inhibits NF-\u03baB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma","volume":"40","author":"Gang","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/j.febslet.2010.10.032","article-title":"Menin stimulates homology-directed DNA repair","volume":"584","author":"Gallo","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_42","first-page":"4204","article-title":"Menin associates with FANCD2, a protein involved in repair of DNA damage","volume":"63","author":"Jin","year":"2003","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2016.3503","article-title":"Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: \u039dew trends in the development of miRNA therapeutic strategies in oncology (Review)","volume":"49","author":"Gambari","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_44","first-page":"347","article-title":"Antisense oligonucleotides: Basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1165\/rcmb.2006-0227TR","article-title":"Regulation of microRNA by antagomirs: A new class of pharmacological antagonists for the specific regulation of gene function?","volume":"36","author":"Mattes","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.1021\/bi0485732","article-title":"LNA (locked nucleic acid): High-affinity targeting of complementary RNA and DNA","volume":"43","author":"Vester","year":"2004","journal-title":"Biochemistry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2015.08.011","article-title":"Small molecules targeting microRNA for cancer therapy: Promises and obstacles","volume":"219","author":"Wen","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","article-title":"MicroRNA sponges: Progress and possibilities","volume":"16","author":"Ebert","year":"2010","journal-title":"RNA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-60761-863-8_3","article-title":"The principles of MiRNA-masking antisense oligonucleotides technology","volume":"676","author":"Wang","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Rajewsky","year":"2005","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/epi-2020-0439","article-title":"Antagomir technology in the treatment of different types of cancer","volume":"13","author":"Preethi","year":"2021","journal-title":"Epigenomics"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Murdaca, G., Tonacci, A., Negrini, S., Greco, M., Borro, M., Puppo, F., and Gangemi, S. (2019). Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163938"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e13208","DOI":"10.1111\/ecc.13208","article-title":"Therapeutic potential of antagomiRs in haematological and oncological neoplasms","volume":"29","author":"Innao","year":"2020","journal-title":"Eur. J. Cancer Care"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","article-title":"Specificity, duplex degradation and subcellular localization of antagomirs","volume":"35","author":"Krutzfeldt","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/gt.2011.100","article-title":"Chemical modification and design of anti-miRNA oli-gonucleotides","volume":"18","author":"Lennox","year":"2011","journal-title":"Gene Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Dasgupta, I., and Anushila Chatterjee, A. (2021). Recent Advances in miRNA Delivery Systems. Methods Protoc., 4.","DOI":"10.3390\/mps4010010"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/gt.2008.57","article-title":"A novel magnetic approach to enhance the efficacy of cell-based gene therapies","volume":"15","author":"Muthana","year":"2008","journal-title":"Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1021\/acs.accounts.9b00101","article-title":"Theranostic Nanoparticles for RNA-Based Cancer Treatment","volume":"52","author":"Revia","year":"2019","journal-title":"Acc. Chem Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1073\/pnas.0803746106","article-title":"Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles","volume":"106","author":"Hofmann","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/gcc.20621","article-title":"Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas","volume":"48","author":"Kirsch","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_64","first-page":"624","article-title":"Glucose-induced microRNA-17 promotes pancreatic beta cell proliferation through down-regulation of Menin","volume":"19","author":"Lu","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"562","DOI":"10.18632\/oncoscience.79","article-title":"Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells","volume":"1","author":"Gurung","year":"2014","journal-title":"Oncoscience"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","article-title":"MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior","volume":"24","author":"Roldo","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 down-regulation in pituitary adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J. Cell Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/JOE-18-0278","article-title":"miR-15a\/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs","volume":"240","author":"Lines","year":"2018","journal-title":"J. Endocrinol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:27:51Z","timestamp":1760164071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":68,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147352"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147352","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2021,7,8]]}}}